Guidant Corp.

Recent Events

News & Analysis

guidant corp. and patient - All News and Analysis

• Guidant Announces Enrollment of First Patient in Landmark Carotid Artery Stenting Study; 10,000-Patient Study Aims to Further Understand Patient Safety, Increase Patient Access

  - 2006-03-17

  INDIANAPOLIS & SANTA CLARA, Calif. -- Guidant Corporation (NYSE:GDT) today announced that the first patient has been enrolled in a new post-approval study of carotid artery stenting in high surgical risk patients, called CAPTURE 2 (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events). A key objective of CAPTURE 2...

  Tags: Guidant Corp., patient

• Guidant Announces Updated and Positive Results of Real-World Carotid Artery Stenting Study; Results from 2,500 Patients Suggest Therapy Can Be Performed Safely by Broad Group of Physicians

  - 2006-03-14

  INDIANAPOLIS & ATLANTA -- Guidant Corporation (NYSE:GDT) today announced updated results of 2,500 patients enrolled in its post approval study of carotid artery stenting, called CAPTURE (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events). Results were presented today during the Late Breaking Registry Session at the American College of...

  Tags: Guidant Corp., patient, physician, therapy

• Guidant Announces Enrollment of First Patient in Clinical Trial of the World's First Fully Bioabsorbable Drug Eluting Coronary Stent.

  - 2006-03-09

  INDIANAPOLIS & SANTA CLARA, Calif., Mar 9, 2006 CCNMatthews via COMTEX -- Innovative Technology Could Represent New Frontier in the Treatment of Heart Disease INDIANAPOLIS & SANTA CLARA, Calif., Mar 9, 2006 CCNMatthews via COMTEX -- Innovative Technology Could Represent New Frontier in the...

  Tags: clinical trial, Guidant Corp., patient

• Guidant Enrolls 300 Patients in Drug Eluting Stent Pivotal Trials and Completes Manufacturing Audit; Successful Inspection Brings Company One Step Closer to European Approval

  - 2005-09-21

  INDIANAPOLIS -- Drug Eluting Stent Milestone Results in Payment to Novartis in Third Quarter

  Tags: Guidant Corp., manufacturing, patient

• Guidant Announces FDA Approval of Wireless Home Patient Management System; Innovative Technology Directed Toward Compliance in Heart Failure Patients at Risk of Sudden Cardiac Death

  - 2005-09-19

  INDIANAPOLIS & ST. PAUL, Minn. -- Guidant Corporation (NYSE:GDT) today announced U.S. Food and Drug Administration FDA approval of the LATITUDER Communicator, and secure data storage system. These elements represent the final components of the LATITUDE Patient Management system, which presently can be used with the CONTAK RENEWALR 3RF cardiac...

  Tags: compliance, FDA, Guidant Corp., patient, wireless

• FDA Classifies Prior Guidant Recalls; Guidant Reiterates its Previous Physician and Patient Recommendations

  - 2005-07-01

  INDIANAPOLIS -- Guidant Corporation (NYSE:GDT) said today that FDA has classified its June 17, 2005 and June 24, 2005 physician communications regarding certain devices.

  Tags: FDA, Guidant Corp., patient, physician

• Guidant Requests Independent Panel to Recommend Physician and Patient Communication Guidelines

  - 2005-06-22

  INDIANAPOLIS -- Guidant Corporation (NYSE:GDT) today announced its intention to establish an independent panel of experts to recommend guidelines for when to disseminate information to physicians and patients about life-sustaining implantable devices.

  Tags: Guidant Corp., patient, physician

• Guidant receives FDA approval for small vessel cobalt chromium coronary stent.(OBSERVATIONS)

  - 2004-11-01

  Guidant Corporation has announced U.S. Food and Drug Administration [FDA] approval of the company's newest stent system designed to treat coronary artery disease in small vessels in patients with abrupt or threatened abrupt closure. The cobalt chromi Guidant Corporation has announced U.S. Food and Drug Administration...

  Tags: FDA, Guidant Corp., patient, vessel

• Guidant Announces Plans to Initiate Groundbreaking Vulnerable Plaque Study; Goal of Study is to Help Physicians Recognize Patients at Risk of Unexpected Heart Attack

  - 2004-09-27

  INDIANAPOLIS & WASHINGTON -- Guidant Corporation (NYSE:GDT) today announced plans to conduct a study designed to increase clinical understanding of "vulnerable" plaques - lipid-rich coronary lesions that suddenly rupture - that may cause most heart attacks. The study will include 700 acute coronary syndrome patients receiving stents in the United...

  Tags: Guidant Corp., patient, physician

• Guidant Receives Exclusive Expanded Indication for Heart Failure Treatment; Thousands of Additional Patients Now Eligible to Receive Cardiac Resynchronization Therapy Defibrillators

  - 2004-09-15

  INDIANAPOLIS & ST. PAUL, Minn. -- Guidant Corporation (NYSE:GDT) today announced that the U.S. Food and Drug Administration FDA has approved an expanded indication for the company's portfolio of cardiac resynchronization therapy defibrillators (CRT-D). The expanded indication makes Guidant's cardiac resynchronization therapy defibrillators available to thousands more heart failure patients,...

  Tags: Guidant Corp., patient, therapy